Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FY8RH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,200
Award facts
- Contract value 100% obligated
- $32,199.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $32,199.67 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL formulations. This firm fixed-price delivery order, issued on December 30, 2025, with an ultimate completion date of December 31, 2025, represents a pediatric or specialty pharmaceutical procurement supporting federal healthcare needs. The contract utilized no set-aside designation and was competitively awarded to AmerisourceBergen's Corporate Office, located in Conshohocken, Pennsylvania.
This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which holds a ceiling value of $999,999,999.00 through December 2026. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs and other federal medical systems, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen demonstrates significant capacity to fulfill diverse pharmaceutical requirements across multiple therapeutic domains through competitively awarded contracts with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DR26FY8RH?
SPE2DR26FY8RH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FY8RH worth?
The government has obligated $32,200 on SPE2DR26FY8RH.
Is contract SPE2DR26FY8RH an order under another contract?
Yes. SPE2DR26FY8RH is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY8RH competed?
The extent of competition for SPE2DR26FY8RH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award